New Way to Study Pulmonary Hypertension in HFpEF

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2023 Nov 9

PMID 37943948

Authors

Zhiyu Dai

Edward Benjamin Thorp

Affiliations

Soon will be listed here.

References

Azarbar S, Dupuis J . Lung capillary injury and repair in left heart disease: a new target for therapy?. Clin Sci (Lond). 2014; 127(2):65-76. DOI: 10.1042/CS20130296. View

Pullamsetti S, Savai R . Macrophage Regulation during Vascular Remodeling: Implications for Pulmonary Hypertension Therapy. Am J Respir Cell Mol Biol. 2017; 56(5):556-558. DOI: 10.1165/rcmb.2017-0033ED. View

Meng Q, Lai Y, Kelly N, Bueno M, Baust J, Bachman T . Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction. Am J Respir Cell Mol Biol. 2017; 56(4):497-505. PMC: 5449511. DOI: 10.1165/rcmb.2016-0177OC. View

Tong D, Schiattarella G, Jiang N, May H, Lavandero S, Gillette T . Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction. Circulation. 2019; 140(21):1769-1771. PMC: 6993895. DOI: 10.1161/CIRCULATIONAHA.119.042267. View

Zawia A, Arnold N, West L, Pickworth J, Turton H, Iremonger J . Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension. Arterioscler Thromb Vasc Biol. 2020; 41(1):430-445. PMC: 7752239. DOI: 10.1161/ATVBAHA.120.314639. View

Agrawal V, Kropski J, Gokey J, Kobeck E, Murphy M, Murray K . Myeloid Cell Derived IL1β Contributes to Pulmonary Hypertension in HFpEF. Circ Res. 2023; 133(11):885-898. PMC: 10655859. DOI: 10.1161/CIRCRESAHA.123.323119. View

Obokata M, Kane G, Reddy Y, Melenovsky V, Olson T, Jarolim P . The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction. Eur Heart J. 2019; 40(45):3707-3717. PMC: 7963136. DOI: 10.1093/eurheartj/ehz626. View

Ranchoux B, Nadeau V, Bourgeois A, Provencher S, Tremblay E, Omura J . Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease. Circ Res. 2019; 125(4):449-466. DOI: 10.1161/CIRCRESAHA.118.314555. View

Thenappan T, Shah S, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P . Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2011; 4(3):257-65. DOI: 10.1161/CIRCHEARTFAILURE.110.958801. View

10.

Fayyaz A, Edwards W, Maleszewski J, Konik E, DuBrock H, Borlaug B . Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction. Circulation. 2017; 137(17):1796-1810. PMC: 5915920. DOI: 10.1161/CIRCULATIONAHA.117.031608. View

11.

Lai Y, Tabima D, Dube J, Hughan K, Vanderpool R, Goncharov D . SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Circulation. 2016; 133(8):717-31. PMC: 4766041. DOI: 10.1161/CIRCULATIONAHA.115.018935. View

12.

Assad T, Hemnes A, Larkin E, Glazer A, Xu M, Wells Q . Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension. J Am Coll Cardiol. 2016; 68(23):2525-2536. PMC: 5157701. DOI: 10.1016/j.jacc.2016.09.942. View

13.

Brittain E, Thenappan T, Huston J, Agrawal V, Lai Y, Dixon D . Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association. Circulation. 2022; 146(7):e73-e88. PMC: 9901193. DOI: 10.1161/CIR.0000000000001079. View

14.

Inampudi C, Silverman D, Simon M, Leary P, Sharma K, Houston B . Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction. Chest. 2021; 160(6):2232-2246. PMC: 8727853. DOI: 10.1016/j.chest.2021.08.039. View